Correlation Between Monopar Therapeutics and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Puma Biotechnology, you can compare the effects of market volatilities on Monopar Therapeutics and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Puma Biotechnology.
Diversification Opportunities for Monopar Therapeutics and Puma Biotechnology
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Monopar and Puma is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Puma Biotechnology
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 0.84 times more return on investment than Puma Biotechnology. However, Monopar Therapeutics is 1.19 times less risky than Puma Biotechnology. It trades about 0.24 of its potential returns per unit of risk. Puma Biotechnology is currently generating about 0.02 per unit of risk. If you would invest 1,923 in Monopar Therapeutics on September 14, 2024 and sell it today you would earn a total of 502.00 from holding Monopar Therapeutics or generate 26.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. Puma Biotechnology
Performance |
| Timeline |
| Monopar Therapeutics |
| Puma Biotechnology |
Monopar Therapeutics and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Puma Biotechnology
The main advantage of trading using opposite Monopar Therapeutics and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Monopar Therapeutics vs. Puma Biotechnology | Monopar Therapeutics vs. Iovance Biotherapeutics | Monopar Therapeutics vs. Sarepta Therapeutics | Monopar Therapeutics vs. Day One Biopharmaceuticals |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |